Logo image of PTN

PALATIN TECHNOLOGIES INC (PTN) Stock Fundamental Analysis

NYSEARCA:PTN - NYSE Arca - US6960775020 - Common Stock - Currency: USD

0.0941  -0.08 (-44.65%)

Fundamental Rating

2

Taking everything into account, PTN scores 2 out of 10 in our fundamental rating. PTN was compared to 550 industry peers in the Biotechnology industry. PTN may be in some trouble as it scores bad on both profitability and health. PTN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PTN had negative earnings in the past year.
In the past year PTN has reported a negative cash flow from operations.
In the past 5 years PTN always reported negative net income.
In the past 5 years PTN reported 4 times negative operating cash flow.
PTN Yearly Net Income VS EBIT VS OCF VS FCFPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

PTN has a Return On Assets of -625.34%. This is amonst the worse of the industry: PTN underperforms 97.15% of its industry peers.
Industry RankSector Rank
ROA -625.34%
ROE N/A
ROIC N/A
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTN Yearly ROA, ROE, ROICPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K -20K

1.3 Margins

With an excellent Gross Margin value of 1255.00%, PTN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PTN's Gross Margin has declined in the last couple of years.
PTN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1255%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
PTN Yearly Profit, Operating, Gross MarginsPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K

More info and screens

0

2. Health

2.1 Basic Checks

PTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PTN has more shares outstanding
PTN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PTN has been reduced compared to a year ago.
PTN Yearly Shares OutstandingPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
PTN Yearly Total Debt VS Total AssetsPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -171.53, we must say that PTN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PTN (-171.53) is worse than 98.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -171.53
ROIC/WACCN/A
WACC10.35%
PTN Yearly LT Debt VS Equity VS FCFPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PTN has a Current Ratio of 0.38. This is a bad value and indicates that PTN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.38, PTN is not doing good in the industry: 94.48% of the companies in the same industry are doing better.
PTN has a Quick Ratio of 0.38. This is a bad value and indicates that PTN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.38, PTN is not doing good in the industry: 94.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
PTN Yearly Current Assets VS Current LiabilitesPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.31% over the past year.
Looking at the last year, PTN shows a very negative growth in Revenue. The Revenue has decreased by -95.07% in the last year.
The Revenue for PTN have been decreasing by -40.52% on average. This is quite bad
EPS 1Y (TTM)40.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)-95.07%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%

3.2 Future

PTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.24% yearly.
PTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 162.67% yearly.
EPS Next Y51.7%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PTN Yearly Revenue VS EstimatesPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 2030 0 100M 200M 300M 400M 500M
PTN Yearly EPS VS EstimatesPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

PTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
PTN is valuated cheaply with a Price/Forward Earnings ratio of 0.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PTN indicates a rather cheap valuation: PTN is cheaper than 99.64% of the companies listed in the same industry.
PTN is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.14
PTN Price Earnings VS Forward Price EarningsPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTN Per share dataPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PTN's earnings are expected to grow with 48.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.7%
EPS Next 3Y48.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PALATIN TECHNOLOGIES INC

NYSEARCA:PTN (5/7/2025, 8:04:01 PM)

0.0941

-0.08 (-44.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-20 2025-05-20/bmo
Inst Owners14.18%
Inst Owner Change0.22%
Ins Owners0.72%
Ins Owner Change2.24%
Market Cap2.45M
Analysts80
Price Target7.14 (7487.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48%
Min EPS beat(2)24.29%
Max EPS beat(2)71.71%
EPS beat(4)3
Avg EPS beat(4)25.29%
Min EPS beat(4)-5.65%
Max EPS beat(4)71.71%
EPS beat(8)3
Avg EPS beat(8)-26.04%
EPS beat(12)6
Avg EPS beat(12)-12.52%
EPS beat(16)8
Avg EPS beat(16)-16.16%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-58.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)63.04%
EPS NY rev (1m)0%
EPS NY rev (3m)40.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.14
P/S 6.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.54
EYN/A
EPS(NY)0.69
Fwd EY729.86%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.01
BVpS-0.25
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -625.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1255%
FCFM N/A
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.53%
Cap/Sales 1.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -171.53
F-Score3
WACC10.35%
ROIC/WACCN/A
Cap/Depr(3y)120.27%
Cap/Depr(5y)96.16%
Cap/Sales(3y)9.17%
Cap/Sales(5y)16.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y51.7%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue 1Y (TTM)-95.07%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%
EBIT growth 1Y1.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.15%
OCF growth 3YN/A
OCF growth 5YN/A